Tocilizumab (Actemra)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 15:43, 6 August 2019 by Jwarner (talk | contribs)
Jump to navigation Jump to search

Mechanism of action

Monoclonal antibody directed against the IL-6 receptor

Diseases for which it is used

History of changes in FDA indication

  • 1/8/2010: Initial FDA approval for rheumatoid arthritis

Also known as

  • Brand name: Actemra
Retrieved from "https://hemonc.org/w/index.php?title=Tocilizumab_(Actemra)&oldid=39412"